These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1979635)

  • 61. The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Derkx FH; Mulder P; Schalekamp MA
    Clin Pharmacol Ther; 1987 Oct; 42(4):411-9. PubMed ID: 2889554
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S12-5. PubMed ID: 2439811
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study of pindolol given once daily in a dose of 15 mg in arterial hypertension].
    Barraine R; Bouchez C
    Nouv Presse Med; 1978 Sep; 7(31):2765-6. PubMed ID: 30959
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of bopindolol on renal function.
    Fabre J; Wintsch J; Peter-Contesse R; Bouchardy C; Liniger C; Favre L; Donath A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S45-50. PubMed ID: 2439819
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
    Dvorák I; Blaha M; Nĕmcová H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):144S-146S. PubMed ID: 1673616
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity.
    Aellig WH
    Br J Clin Pharmacol; 1985 Jun; 19(6):775-81. PubMed ID: 2862891
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term blood pressure control with pindolol given once daily.
    Frithz G; Danielson M; Henningsen N; Malmborg RO; Nordström-Ohrberg G; Schröder G
    Eur J Cardiol; 1978; 7(2-3):131-6. PubMed ID: 27369
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of the antihypertensive effect of a beta-blocker with the aid of daily blood pressure profiles.
    Abetel G; Karly M; Genoud G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S77-9. PubMed ID: 2439827
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

  • 70. Withdrawal of the long-acting beta blocker bopindolol is not associated with beta-adrenoceptor supersensitivity.
    Bolli P; Amann FW; Müller FB; Meyer B; Burckhardt D; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S64-9. PubMed ID: 2439824
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
    Karlberg BE; Larsson R; Ohman KP; Norlander B; Wirsen A; Hed J; Lundh BL; Flock A
    Eur J Clin Pharmacol; 1983; 25(2):179-86. PubMed ID: 6138257
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Haemodynamic effects of short-term treatment with bopindolol in essential hypertension.
    Fitscha P; Meisner W; Brandstetter G; Tiso B
    Eur J Clin Pharmacol; 1988; 34(4):411-3. PubMed ID: 2900146
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 74. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
    Dorow P; Schiess W
    Klin Wochenschr; 1986 Apr; 64(8):366-9. PubMed ID: 2871220
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Single daily dose of pindolol in the treatment of arterial hypertension].
    Ciaramelli F
    Nouv Presse Med; 1978 Sep; 7(31):2761-4. PubMed ID: 30958
    [No Abstract]   [Full Text] [Related]  

  • 76. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
    Tassy J; Jouve A
    Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
    [No Abstract]   [Full Text] [Related]  

  • 77. Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension.
    Schirger A; Sheps SG; Spiekerman RE; Harman TR; Kleven MK
    Mayo Clin Proc; 1983 May; 58(5):315-8. PubMed ID: 6843182
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study.
    Rapola JM; Pellinen TJ; Toivonen L; Nieminen MS
    Ann Med; 1990; 22(4):221-4. PubMed ID: 2248757
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Value of a single oral dose of pindolol].
    Safar M; Weiss Y; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2767-8. PubMed ID: 30960
    [No Abstract]   [Full Text] [Related]  

  • 80. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.